Cargando…
Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
Background and objective: An interaction between low-density lipoprotein level, lipid-lowering drugs, and systemic lupus erythematosus (SLE) was reported by previous studies. However, whether lipid-lowering drugs provided protective effect for reducing the risk of SLE was unclear. We aimed to clarif...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642506/ https://www.ncbi.nlm.nih.gov/pubmed/37964871 http://dx.doi.org/10.3389/fphar.2023.1258018 |